AstraZeneca Gets in on ADC Therapeutics' Mega $200M Funding Round Post author:Sam Post published:October 22, 2017 Post category:BioPharma ADC Therapeutics announced it had raised $200M through an oversubscribed private placement. Source: BioSpace You Might Also Like Bay Area's Avinger Axes Jobs, Q3 Sales Down 61% November 13, 2017 Novartis Poised for Growth as CEO Hands Baton to Successor January 23, 2018 Arcturus Rockets on New Hep B RNA Deal With Johnson & Johnson October 18, 2017